Infectious morbidity in critically ill patients with cancer Journal Article
| Authors: | Safdar, A.; Armstrong, D. |
| Article Title: | Infectious morbidity in critically ill patients with cancer |
| Abstract: | Infection frequently complicates the course of cancer treatment and often adversely affects the outcome. Patients have a greater tendency for acquiring infections caused by opportunistic microorganisms. Agents with low virulence potential may lead to invasive and often life-threatening infections because of altered host immune function. The immune dysfunction may be caused by the underlying malignancy, by antineoplastic chemotherapy, or by invasive procedures during supportive care. |
| Keywords: | review; alpha interferon; cancer patient; cytarabine; methotrexate; antineoplastic agent; neoplasms; unindexed drug; etoposide; morbidity; cyclophosphamide; vincristine; high risk patient; mitoxantrone; daunorubicin; sepsis; virus infection; clarithromycin; immune deficiency; tetracycline; azithromycin; cotrimoxazole; levofloxacin; quinoline derived antiinfective agent; rifampicin; bacterial infection; antibiotic prophylaxis; pentamidine; mycosis; tioguanine; antibody formation; granulocytopenia; ofloxacin; vidarabine; infection complication; opportunistic infection; erythromycin; mercaptopurine; critical illness; immunity, cellular; ivermectin; ceftazidime; mycoses; carbapenem; meropenem; imipenem; agranulocytosis; shock, septic; respiration, artificial; cancer; humans; human; priority journal; cilastatin; tiabendazole |
| Journal Title: | Critical Care Clinics |
| Volume: | 17 |
| Issue: | 3 |
| ISSN: | 0749-0704 |
| Publisher: | W.B. Saunders Co. |
| Date Published: | 2001-07-01 |
| Start Page: | 531 |
| End Page: | 570 |
| Language: | English |
| DOI: | 10.1016/s0749-0704(05)70198-6 |
| PUBMED: | 11525048 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 21 May 2015 -- Source: Scopus |
